Overview

Hepatocellular Carcinoma Imaging Using PSMA PET/CT

Status:
Recruiting
Trial end date:
2023-09-08
Target enrollment:
Participant gender:
Summary
The purpose of the research is to evaluate the use of a PSMA PET/CT (Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography) scan in the diagnosis of HCC (hepatocellular carcinoma) and comparing it to standard scanning techniques with CT (Computed Tomography) or MRI (Magnetic Resonance Imaging).
Phase:
Phase 2
Details
Lead Sponsor:
Peter MacCallum Cancer Centre, Australia